P/E ratio for Zynex (ZYXI)
P/E ratio as of May 2024 (TTM): 26.8
According to Zynex's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 26.8372. At the end of 2022 the company had a P/E ratio of 30.9.
P/E ratio history for Zynex from 2004 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 30.9 | 50.06% |
| 2021 | 20.6 | -59.6% |
| 2020 | 51.0 | 87.87% |
| 2019 | 27.1 | 167.69% |
| 2018 | 10.1 | -26.67% |
| 2017 | 13.8 | -69.2% |
| 2016 | 44.9 | -1097.48% |
| 2015 | -4.50 | 429.41% |
| 2014 | -0.8500 | -47.16% |
| 2013 | -1.61 | -111.49% |
| 2012 | 14.0 | 23.53% |
| 2011 | 11.3 | -79.25% |
| 2010 | 54.6 | 312.29% |
| 2009 | 13.2 | -96.73% |
| 2008 | 405 | 2431.45% |
| 2007 | 16.0 | -161.54% |
| 2006 | -26.0 | |
| 2004 | -7.50 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Medtronic MDT | 29.8 | 10.85% | 🇮🇪 Ireland |
 Rockwell Medical
RMTI | -1.85 | -106.90% | 🇺🇸 USA |
 Fonar Corporation
FONR | 10.9 | -59.34% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.